TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
RGEN

Repligen Corporation

Healthcare · Medical Instruments & Supplies

186.80$ +3.3% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow RGEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
29.0% 18.0% 7.2% 12.4% 16.9% 24.9% 17.1% 17.7% 21.5% 17.8% 27.6% 15.9%
6.3% 5.5% 5.1% 7.4% 8.1% 7.7% 7.4% 5.7% 7.1% 10.7% 13.6% 13.1%
2.8% 4.3% 4.4% 4.8% 5.3% 4.8% 4.6% 4.1% 3.4% 4.0% 7.6% 4.4%
6.6% 9.1% 3.6% -12.7% 5.3% 6.9% 3.6% 5.2% 3.2%
3.2% -7.7% -14.8% -5.3% -7.3% -1.0% -13.5% -15.2% -8.7% -1.4% 9.6% -6.9%
8.8% 3.1% 4.1% 3.9% 7.2% 8.6% 7.2% 10.0% 16.6% 6.1% 5.2% 3.2%
-31.1% 5.7% -47.1% -69.6% -7.2% -76.0% -55.0% -33.0% -29.1% -13.6% -40.4%
0.0% 0.0% 0.0% 0.0% 0.2% 0.4% 2.1% 88.6%
2.6% 1.0% 1.8% 93.2% 1.8% -0.2% 0.0% -0.4% -2.1% -2.3% -2.3% 0.0%
174.8% 133.0% 106.2% 0.0% 0.0% 60.5% 0.0% 0.0% 0.0% 45.4% -11.0% 0.0%
2.6% 0.9% 107.2% 92.0% 1.8% 179.4% 83.5% 0.1% -1.7% 39.0% -13.1% -2.1%
-7.0% 22.4% 65.2% 36.5% 10.3% 127.1% 49.1% -16.9% -10.0% 35.7% 1.0% -25.9%
20.1% 14.9% 3.1% 8.5% 9.7% 16.3% 9.9% 7.7% 4.8% 11.7% 22.5% 12.7%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?